Dec 17
Trendspotting: Artificial Intelligence, Impact of Global Policies, Data Harmonization
01/06/2026
To kick off 2026, we spoke with industry experts and leaders in the Bio-IT World community about what they expect and look forward to in the new year.
Read the full article featuring Allison Cuff Shimooka from Bio-It World here.
Related Blog Posts
2026 Forecasts From People Smarter Than Me – Part 1
2026 will be defined by uncertainty — geopolitical instability, volatile global markets, and shifting health policies will influence every choice pharma companies make. From clinical trial planning to pipeline priorities, leaders will increasingly weigh innovation against risk, trying to preserve momentum while navigating an unpredictable global landscape. Read the full article featuring Allison Cuff Shimooka…
Nearly a third of clinical trial procedures may not drive results
Clinical trial protocols are among the most complex and resource-intensive documents developed in pharmaceutical and biotechnology research. Designed to define objectives, procedures, participant criteria, and data collection practices, protocols serve as the operational blueprint for evaluating investigational therapies. However, as the range of study endpoints has grown, so too has the volume, complexity, and burden…
Working together to innovate on pragmatic clinical trials, with Rob DiCicco
Process innovation in the pharmaceutical industry is never easy, but its best chance of success comes when companies come together to work on big problems – especially when they bring in regulators and other stakeholders. Listen to the full podcast featuring Rob DiCicco by PharmaPhorum here.